Orkla ASA (ORK) Earnings Call Transcript & Summary

February 8, 2024

Oslo Bors NO Consumer Staples Food Products earnings 42 min

Earnings Call Speaker Segments

Kari Lindtvedt

executive
#1

Good morning, everyone, and welcome to the Fourth Quarter Presentation for Orkla. I'm Kari Lindtvedt, Head of Investor Relations. Joining us today are our President and CEO, Nils Selte, and our CFO, Harald Ullevoldsaeter. Throughout today's presentation, feel free to post your questions in the live chat — we'll address them during the Q&A session at the end of the presentations, along with any questions from the audience. Now, let's get started. I'll hand the floor to Nils to summarize the year 2023 and also our main messages for the quarter we are reporting. Please, Nils, the floor is yours.

Nils Selte

executive
#2

Thank you, Kari, and good morning to all of you. Ahead of my Q4 summary, I'd like to spend a moment looking back over the whole of 2023. My view is that we succeeded in accomplishing the goals we laid out at the start of the year, reshaping Orkla into an industrial investment company focused on brands and the consumer space. It impresses me how the companies in our portfolio have found their way through yet another unusual year. In the markets where we operate, consumers have faced pressure, and the geopolitical situation has remained unstable. In the final quarter of the year, it's gratifying to observe some of the headwinds from 2023 letting up, including reduced pressure on volume, along with signs that input costs are improving. Adjusted earnings per share came in at NOK 5.78, which is 6% higher than in 2022. Among our portfolio companies in 2023, I regard Jotun as a standout. That company makes a major contribution to net profit this year. Jotun's Board plans to propose a dividend of NOK 2.2 billion for the year, and Orkla's portion of that will come to roughly NOK 950 million. Our consolidated portfolio companies, HQ included, achieved underlying EBIT adjusted growth of 7% for the year, and the improvement spans a broad base.

Nils Selte

executive
#3

Cash conversion across the portfolio companies also came up markedly over the year, finishing above 100%. Hydro Power, even though it posted lower EBIT than last year, remains a strong contributor to Orkla's result when viewed historically. Orkla's Board of Directors plans to propose a total dividend of NOK 6 per share for 2023, with NOK 3 of that coming on top of our ordinary dividend. As we said at our Capital Markets Day in November, our main priorities are to strengthen organic value creation and cut complexity within the current portfolio before we look at investing in new portfolio companies. So excess capital from the sale of 40% of Orkla Food Ingredients, along with a higher dividend from Jotun, can be paid out to our shareholders as an additional dividend. At our recent Capital Markets Day, we set out 3 financial targets for the portfolio companies. Hitting these targets will be essential to delivering 12% to 14% total shareholder return over the next 2 years. The left side of this slide shows you how these KPIs came out for 2023. We achieved 7% underlying EBIT adjusted growth, against our communicated KPI of 8% to 10% per annum for the period 2024 to '26. The EBIT adjusted margin came in at 9%, flat versus 2022.

Nils Selte

executive
#4

If you factor in the drag from the new biscuit plant in Latvia ramping up, the underlying trend, in my view, is positive. We also report a return on capital employed of 10% for 2023, and we aim to lift that to 13% by the end of 2026. Throughout 2023, we built full potential plans covering every portfolio company. The potential these plans identify, together with some headwinds easing, leaves me optimistic about the quarters ahead. Let's now look at the Q4 2023 highlights. Earnings came in at NOK 1.3 per share for the quarter, flat versus Q4 2022. Jotun kept growing solidly, and the consolidated portfolio companies, Headquarter included, posted broad-based EBIT adjusted growth. During the quarter, organic sales growth at the consolidated portfolio companies reached the mid-single digit level. Price increases drove that development. Volume/mix overall remained slightly negative, mostly because of Foods Europe, though less so than in earlier quarters. A clear majority of the portfolio companies saw positive volume/mix development in the quarter. Alongside volume performance, we keep a close watch on market share development. In Q4, we are seeing clear signs of improvement.

Nils Selte

executive
#5

This chart displays the EBIT adjusted contribution coming from our portfolio companies during Q4. The boxes shown above it present the rolling 12-month EBIT adjusted margin together with the underlying growth in EBIT adjusted. As was mentioned, the improvement in underlying EBIT adjusted was broad-based this quarter. I'd also like to highlight that broad-based gains in contribution ratio are being reported across our 11 consolidated portfolio companies. A portion of this has been reinvested into A&P spend over the quarter, consistent with the strategy at many of the portfolio companies. In addition, we observed an easing of cost inflation pressure on input cost, which leaves me optimistic about the year ahead. With that positive note, I'd like to pass things over to Harald, who will walk through the financials in more detail.

Harald Ullevoldsæter

executive
#6

Thanks, Nils, and good morning, everyone. I'll walk you through the quarter 4 results now. As with last time, we'll concentrate chiefly on the aggregated figures for the group, and after that we'll go into greater detail on the 8 largest portfolio companies. Operating revenues rose 10% in the fourth quarter, driven mostly by positive organic sales growth at the portfolio companies, chiefly tied to price increases as well as positive currency translation effects. Conversely, lower power prices in Hydro Power had a negative impact on group revenue. EBIT for the consolidated portfolio companies was up 17%, with 7% of that coming from underlying growth, mainly connected to continued organic revenue growth as well as better margins. I'll return to this. The drop in EBIT for financial investment stemmed largely from lower electricity prices for Hydro Power. The Q4 '23 results of NOK 183 million for Hydro Power are high in historical terms, even though that's a significant decline from quarter 4 last year. Net other income and expenses in quarter 4 came to minus NOK 356 million. Other income was NOK 52 million in total, roughly 50% of which related to sales of a factory building in Orkla Foods Cesko a Slovensko as part of the ongoing restructuring project there.

Harald Ullevoldsæter

executive
#7

That said, other costs tied to restructuring projects and group write-downs, plus M&A expenses, offset this. Profit from associates came to NOK 372 million in Q4, driven by a very strong result at Jotun. So net financial costs rose considerably in quarter 4, mainly because of a higher interest rate, but also because of increased debt. The average interest rate stood at 5.5% this quarter versus 3.5% in quarter 4 '22. Reported tax expenses were NOK 290 million, and the lower tax came from a reduced resource rent tax for Hydro Power. Excluding associates, the tax rate was 30%. Profit after tax and non-controlling interests for the quarter came in at NOK 997 million, equal to an adjusted earnings per share of NOK 1.31, matching last year. Now let's look at how the EBIT margin performed this quarter. This chart displays the rolling 12-month EBIT adjusted margin for the consolidated portfolio companies, Headquarters included, from 2019 through quarter 4 '23. As we shared at our Capital Markets Day, and as Nils mentioned, specific targets have been set for 5 of our 11 portfolio companies. Should every one of our consolidated portfolio companies hit its financial targets, we anticipate margin expansion of 150 basis points to 200 basis points across the next 3 years.

Harald Ullevoldsæter

executive
#8

By the close of Q4 2023, the margin stood at 9%. That's still under where margins have historically sat, but we're seeing signs that we've hit the floor, and margins should pick up from here. Our consolidated portfolio companies, Headquarters included, lifted the margin by 10 basis points during Q4. Yet at the same time, A&P as a share of net sales value rose by 30 basis points, and the temporary issues at the biscuit factory dragged margin down by a further 20 basis points. As the right-hand side of the slide shows, the underlying EBIT adjusted margin improved at 9 of our 11 portfolio companies versus Q4 2022. Within Confectionery & Snacks, margin is held back by the difficulties tied to ramping up the biscuit factory, while the margin drop at Orkla Health stems from a substantial step-up in A&P spend in Q4. Let's turn now to the organic growth breakdown. I realize this slide is busy, so allow me to take you through it. The chart breaks organic top line growth into volume/mix and price. We see the yearly trend from 2019 through 2023, plus quarterly figures running from Q4 2022 to Q4 2023.

Harald Ullevoldsæter

executive
#9

For the consolidated portfolio companies, organic growth came in at 5.3% during the quarter. And as the graph shows, price has been the primary engine behind that organic growth — it has mostly been price in recent quarters. At this point, though, we are seeing an early sign that volume performance is improving. As the table on the right makes clear, this shows up in the volume/mix results at most of our portfolio companies. The biggest challenge relates to Orkla Foods Europe, which continues to post a year-over-year decline in volume performance. Yet when we look across the individual markets, we also notice indications of improvement. We should also stress that the contribution from price increases in previous periods has to be viewed against substantial rises in input costs. As Nils said, we think this situation will get better going forward. And we expect the contribution from price to be gradually reduced. Let's turn to cash flow. Total cash flow from operation was NOK 7.1 billion in 2023, versus NOK 3.8 billion in 2022. Cash flow from operation from consolidated portfolio companies came to NOK 6.6 billion in 2023, versus NOK 1.9 billion in 2022. The primary factor was a decrease in working capital, compared with a substantial increase last year.

Harald Ullevoldsæter

executive
#10

That was specifically tied to bringing inventory levels down toward more normalized levels. The biggest project within net replacement investments was the construction of the biscuit factory in Latvia. This item, though, also covers a number of other factory and warehouse projects. The drop in operating cash flow from financial investments is connected to the lower profit for Hydro Power, which we described earlier. In addition, we'd like to highlight that cash conversion is a key metric for our consolidated portfolio companies, and we have already communicated cash conversion targets for these at the Capital Markets Day. Going forward, we will keep an eye on this metric to make sure our companies perform satisfactorily. And in 2023, cash conversion for the consolidated portfolio companies, including Headquarters, came in at 102%. We expect the favorable trend in operating cash flow to carry on in 2024, thanks to greater capital discipline and also the fact that there is still room to reduce working capital. Let me now take you through the net interest-bearing debt bridge as of year-end 2023. Net interest-bearing debt, including leases, rose by NOK 1.7 billion from year-end 2022, reaching NOK 18.8 billion at December 2023. Financial items were hit negatively by higher interest rates and a higher debt level.

Harald Ullevoldsæter

executive
#11

As I mentioned, we also distributed NOK 3.1 billion in dividends during April. Net M&A and expansion CapEx came to NOK 1.7 billion in 2023, with NOK 949 million of that tied to company purchases — chiefly the acquisitions of Bubs Godis in Sweden and Khell-Food in Hungary. The rise in expansion CapEx was largely attributable to Orkla Food Ingredients, Orkla Confectionery & Snacks, and Orkla Health, where money has gone into greater production and warehouse capacity, along with new production lines. ForEx effects took a negative hit from the Norwegian krone weakening against the euro and U.S. dollar. At December 2023, net interest-bearing debt through the last 12 months EBITDA stood at 2.0x, the same as in quarter 3. And when adjusted for the Orkla Food Ingredients transaction, which hasn't closed yet, that ratio drops to 1.7x. Let's now take a closer look at how the 8th biggest, largest portfolio companies performed. Beginning with Jotun, sales kept climbing in the fourth quarter of 2023, with reported year-over-year sales growth of 9%. Once currency translation effects are adjusted for, underlying sales growth was 11%. This positive sales performance came from a combination of volume growth, a higher average selling price, and positive mix effects.

Harald Ullevoldsæter

executive
#12

In protective, sales growth was especially robust, while decorative and powder likewise posted solid volume gains. Fourth-quarter EBITA rose 83%, supported by higher sales, an improved gross margin, and effective cost containment. The gross margin uplift came primarily from cheaper raw materials. Jotun has begun 2024 with healthy sales momentum and heads into the year anticipating further growth in both sales and earnings, though at a slower pace than during the exceptional post-pandemic period. Raw material costs should stay stable and keep supporting healthy gross margins through the first half. Additionally, as Nils mentioned, Jotun's Board of Directors has signaled its intent to propose a dividend of NOK 2.2 billion, with Orkla's portion at NOK 948 million versus NOK 365 million received in 2023. Turning to Orkla Foods Europe, organic sales there rose 5.1% in the fourth quarter. Gains were broad-based across every channel, mainly fueled by price rises. Grocery volume performance overall was less negative than in earlier quarters, and Norway saw positive volume development during the quarter. Grocery market share results were, by and large, somewhat improved relative to the prior quarter.

Harald Ullevoldsæter

executive
#13

In the out-of-home channel, sales continued to grow, though volume performance came in a bit softer than it had in earlier quarters of 2023. We saw underlying EBIT growth of 6%, helped along by a better contribution ratio and by cost savings from reorganization projects in Norway, Sweden, and the Czech Republic. Input costs remain a challenge, but things appear to be settling down. That said, weak currency exchange rates are adding further pressure on purchasing costs in Norway and Sweden. In the fourth quarter, the EBIT margin came in at 11.5%. The underlying change was a positive 10 basis points. To offset these pressures from higher costs and softer volumes, we put cost and efficiency improvement programs in place during 2023. At the close of 2022, the Czech Republic organization underwent extensive restructuring and streamlining, and that process paid off in 2023. On top of that, we have taken steps to cut down category and product complexity. That also involves simplifying the production setup: one factory has been shut down, one has been divested, and another 2 are under evaluation at present. We expect this work to wrap up in the first half of 2024. Turning to Orkla Confectionery & Snacks, organic sales rose 8.1% in the quarter, with 1.3% of that coming from volume/mix growth.

Harald Ullevoldsæter

executive
#14

On the whole, the market performed well, and our share of the snacks segment rose. The biscuits side had delivery problems that showed up mainly in Sweden and the Baltics, which held back volume and share gains overall. EBIT for the quarter came in at NOK 348 million, and underlying EBIT was down roughly 7%. Production at the new biscuit plant was better in the fourth quarter. Even so, output on some lines remains under plan. The total estimated hit to underlying EBIT was NOK 25 million in the quarter and NOK 150 million across the full year, consistent with what we said before. We expect these difficulties to persist into 2024, though, as we noted at Capital Markets Day, a substantial portion of the adverse 2023 effects should be recovered during 2024. Prices for raw materials gradually stabilized across most purchasing categories, yet they remained above the level of the same quarter a year earlier. Prices for certain raw materials, including sugar and cocoa, climbed sharply in the quarter. In addition, a weaker currency weighed on the overall cost base in Norway and Sweden. Price increases offset the higher costs, but they still diluted the EBIT margin.

Harald Ullevoldsæter

executive
#15

Now let's turn to Orkla Food Ingredients. During the quarter, Orkla Food Ingredients posted organic revenue growth of 1.1%. Throughout the year, price increases have been the primary engine behind organic growth, though their effect has steadily diminished as raw material prices stabilized. On top of that, volume/mix was down 1.8%. That decline mirrors tough comparables in the margarine segment within plant-based. In bakery and sweet, volume performance is broadly consistent with how 2023 played out, with a modest dip caused by weaker consumer purchasing power and a move toward lower-priced products in certain markets, which hurt mix. A number of segments and markets across the different clusters did achieve volume/mix growth in quarter 4. Underlying EBIT rose 10.3% in the quarter, supported by solid revenue management and operational improvements. We're pleased to see strong momentum in several European markets, along with solid results from Denali, which is performing in line with plan. The EBIT margin came in at 5.5% for the fourth quarter, which equates to underlying EBIT margin growth of 0.5 percentage points versus quarter 4 2022. Now let's look at Orkla Health. Orkla Health delivered organic growth of 5.8% in the quarter. That organic growth came from broad-based price increases and from volume growth in Health's international markets, together with continued subscription growth at NutraQ.

Harald Ullevoldsæter

executive
#16

On the market side, store brands keep gaining share in grocery, and that trend was particularly clear in Norway. Underlying EBIT fell 6.8% for the quarter, with the decline attributable to higher advertising spending. That aligns with the strategic plan aimed at backing omni-channel implementation and speeding up international expansion. The EBIT margin came in at 6.8% in quarter 4, versus 8.1% in quarter 4 2022. Turning to Orkla India: organic growth there was 12.4% for the quarter, powered by both price and volume. Growth was broad-based across core categories, in home markets as well as the international business. Underlying EBIT rose 22.5% in the quarter, helped by a NOK 22 million grant from the Government of India. Without that government grant, underlying EBIT was down 8% year-over-year, which reflects heavier advertising spend to drive festival sales, higher personnel expenses, and rising factory costs. The EBIT margin improved by 1 percentage points, reaching 11.9% against the same period in 2022. Next, The European Pizza Company: The European Pizza Company posted underlying EBIT growth of 10.8% for the quarter. That gain came from the restructured cost base in Germany, which also gave underlying EBIT margin a positive lift.

Harald Ullevoldsæter

executive
#17

We also saw structural margin improvement from the Da Grasso acquisition. A 2.1% organic increase came primarily from price hikes aimed at offsetting elevated costs of raw materials used in pizza dough and ingredients. Consumer sales for quarter 4 came to EUR 107.8 million, which equates to an underlying decline of 0.8% in consumer sales. For markets outside Germany, underlying growth in consumer sales reached 4.5%. Restructuring carried on in Germany during the fourth quarter so we can secure a robust platform and a more streamlined organization. By the close of quarter 4, the business operated 825 sales outlets, after 14 outlets in Germany were closed during that quarter. Across 2023, 54 outlets in total were shut down in Germany. Additionally, we recorded a goodwill write-down of NOK 62 million in the quarter, roughly 1/3 of all goodwill tied to the 2021 acquisition in Germany. Turning to Orkla Home & Personal Care, underlying EBIT rose 65%. That gain stemmed from robust organic growth along with cost improvement measures. Organic growth in the quarter reached 11.5%, fueled by both price and volume, with strong results in Norway on solid volume growth, together with price growth in Sweden and Finland.

Harald Ullevoldsæter

executive
#18

It's also worth mentioning that we're seeing positive market share results in the Norwegian grocery sector measured on a rolling 3-month basis. The contribution ratio saw improvement during the quarter, helped along by revenue management and price increases, though this was partly offset by higher input costs and by the NOK weakening against the euro. The cost improvement measures we put in place in the second quarter, which related to sales and administrative functions, contributed positively during the quarter. Let's take a brief look at the remaining 4 portfolio companies. When it comes to the remaining portfolio companies, we're pleased to observe positive performance across all of them. And we're working hard right now to keep this positive momentum going forward. On relevant news, we'd like to highlight that we've successfully relocated the warehouse in HSNG to a fully automated warehouse, with limited impact for the end customer during the implementation. And before I hand the floor back to Nils for his final remarks, I'd like to draw your attention to the appendices of this presentation. We've included an overview of the financial targets for each of the consolidated portfolio companies that were communicated at our Capital Markets Day together with the outcome of 2023.

Harald Ullevoldsæter

executive
#19

You'll also find a breakdown of costs for the year there. Thank you.

Nils Selte

executive
#20

Thanks, Harald. Our Q4 report comes with a more positive tone than we had in earlier quarters, even though comparables were soft. What matters more is that we're observing encouraging movement across a number of important drivers — volume, input cost, and market share among them. I'm also very glad — very pleased — to see Jotun continuing to perform strongly, along with strong cash flow from operations coming out of the consolidated portfolio companies, Headquarters included. As mentioned, the Orkla Board of Directors plans to propose a dividend of NOK 6 per share for the year. Sorry, I missed the slides. Then, on the last slide before we go to the Q&A, I'd also like to restate the 3 commitments I made at the Capital Markets Day. Driving organic value in our existing portfolio is our #1 priority. Second, we are committed to reducing complexity. And finally, we are exploring value-adding structural transactions that are ready for execution if and when the timing is right. Thank you. We'll now move on to the Q&A.

Kari Lindtvedt

executive
#21

Thank you, Nils and Harald. A few questions have come in from the web. First, though, let me check whether anyone in the audience would like to ask something. Please give your name and company. All right. In that case, we'll begin with some of the web questions. Patrick Folan, Barclays. It seems the tide is turning in your markets. As we head into 2024, what are your expectations for volume performance in your markets? Could you comment on the volume exit rates from Q4, and on which segments you expect to improve the most? In which countries is volume elasticity improving? And I'll take the second part of the question afterwards.

Nils Selte

executive
#22

All right, let's go ahead and begin. As I mentioned, we observed some easing across our markets, and most of the portfolio companies posted positive volume growth during the last quarter. We're also seeing that trend carry forward, and the impact appears stronger toward the end of the quarter than at its start. We anticipate this will persist as we move through this year. If you're thinking about guidance for the first half of this year, we feel quite optimistic regarding volume for our portfolio companies. When you look at the first quarter, keep in mind that the Easter effect will weigh on it negatively. So please bear that in mind. Harald, perhaps you'd like to add something?

Harald Ullevoldsæter

executive
#23

No, just a reminder that for most of our portfolio companies, we do have volume growth. As I mentioned in my presentation, this is mostly tied to Orkla Foods Europe and, to some extent, Orkla Food Ingredients. The main problem, though, is Orkla Foods Europe. As I said, we also saw volume growth in Norway.

Kari Lindtvedt

executive
#24

After that, I'll pick up the second portion of the question from Patrick. Given that certain raw material prices are also rising, do you intend to implement some targeted pricing measures as needed?

Nils Selte

executive
#25

Negotiations with our customers are something we do all the time, and if it becomes necessary, we'll raise prices in the upcoming period too, whenever we observe raw material costs going up.

Kari Lindtvedt

executive
#26

Next, we have a question coming from Eirik Rafdal at Carnegie. You sound confident that margins have hit their lowest point. You also mention that you expect margins to increase by 150 basis points to 200 basis points over the next couple of years, provided you execute on the plans for the portfolio companies. Could you give us some thoughts on, first, how the margin expansion will be phased? And second, whether the 150 basis points to 200 basis points represents the first step toward potentially higher margins beyond this?

Harald Ullevoldsæter

executive
#27

Regarding the final part of your question — I'd rather not forecast beyond the complete potential plan and the strategic plans we laid out at our Capital Markets Day. I believe it's far too soon to dig into a number like that. So let's save that for another occasion. If you could remind me of the first part of the question.

Kari Lindtvedt

executive
#28

How the margin is phased.

Nils Selte

executive
#29

I think maybe Harald could dig in on that. He's more into the details there.

Harald Ullevoldsæter

executive
#30

At our Capital Markets Day, we mentioned a total value creation potential of NOK 45 billion. We also noted that this is mostly split evenly across this 2-year period, though perhaps with a larger portion toward the end. And margin, of course, plays a significant role in that value creation journey. So I'd describe it as more or less evenly distributed. That means we need to see margin improvement beginning this year.

Kari Lindtvedt

executive
#31

Thanks. We’ve got three questions from Ole Martin Westgaard at DNB, and I’ll take them one by one. First, could you say how competition from private label has been developing?

Nils Selte

executive
#32

In our market, we’re noticing indications that competition from private label is letting up. If my memory serves me right, I also noticed ICA recently reported some figures, and those show a favorable market trend for them. As we’ve discussed before, I believe we observed customers moving away from supermarkets toward hard discounters. Based on what the ICA numbers from a few days ago indicate, perhaps that movement is reversing slightly. And we’re also seeing evidence that private label is raising prices to a greater extent than we currently are.

Kari Lindtvedt

executive
#33

On your second question, you seem a bit more upbeat about raw material costs. When should we begin to see a favorable effect on your margins?

Harald Ullevoldsæter

executive
#34

I don't believe we'll get any more specific than looking at 2024. And yes, we are seeing a few encouraging signals that raw material prices will ease going forward. We already saw a bit of that by the end of 2023, so an improvement should be expected as we move into 2024.

Nils Selte

executive
#35

Let me add something there. To put it a little more precisely, we're expecting input cost to give us mid-single-digit positive effects going into '24, actually.

Kari Lindtvedt

executive
#36

Alright, the last question comes from Ole Martin. Could you tell us where things stand with the pre-study regarding a possible IPO in India?

Nils Selte

executive
#37

We're not going to comment on that. I believe at the Capital Markets Day we mentioned that a pre-IPO study would be started. Once that study is finished, I think we'll come back to the market. You'll just need to be a little patient, and we'll get back to you.

Kari Lindtvedt

executive
#38

Are there any questions from the audience? Alright. We'll take a couple more that came in online. Oyvind Mossige from SpareBank 1 Markets asks: do you see clear signs of positive margin development for old branded consumer goods going into first half of 2024? I believe you've already covered that.

Harald Ullevoldsæter

executive
#39

Right. I don’t think we’ll specify which portion of 2024 will show improvement, but we did say 2024.

Kari Lindtvedt

executive
#40

Petter Nystrom from ABG Sundal Collier here. Could you go over again your comments about what to expect in 2024 regarding the biscuit factory difficulties? There was a NOK 25 million impact in Q4 — what ought we to anticipate for Q1 and Q2 of 2024?

Nils Selte

executive
#41

I think I'll begin, and Harald can fill in the specifics. But first, at the Capital Markets Day we stated that the overall impact for 2023 would come to roughly NOK 150 million. That's what we also reported today. So that was the guidance, and it was delivered in line with that guidance. And we also mentioned at the Capital Markets Day that a significant portion of it will be reversed as we go into '24. That's something we still stand by. And maybe Harald can offer a few comments on when it will come and affect the numbers?

Harald Ullevoldsæter

executive
#42

So I'd say the recovery will likely be somewhat stronger in the second half of 2024, though we should also see some improvement in the first half.

Kari Lindtvedt

executive
#43

And now it looks like the last question we have coming in from the web. It's Patrick Folan once more from Barclays. In Orkla Health, where exactly are you noticing that shift toward private label? Which categories specifically?

Harald Ullevoldsæter

executive
#44

Regarding Orkla Health, I believe we've had some listings removed in certain markets by some of our customers — they've essentially pulled us from their shelves and replaced us with private label. Honestly, I'd say the situation in Health isn't all that different from what we're seeing in other areas of our business.

Kari Lindtvedt

executive
#45

Alright. Thank you. That appears to be the last question. Does anyone here in the audience have a final question? No? Okay. Before we wrap up, I want to remind everyone that our Annual General Meeting is set for the 18th of April. We'll also report our first quarter results on the 3rd of May. Thanks for being with us today, and enjoy the rest of your day.

Read the full transcript via the API

You're viewing the first half of this call. Get the complete Orkla ASA transcript — plus 132,000+ transcripts from 7,000+ companies, speaker segments, AI summaries and full-text search — through the EarningsCalls.dev API.

Get the API View API docs →

This call discussed

For developers and AI pipelines

Programmatic access to Orkla ASA earnings transcripts and 132,000+ others is available through the EarningsCalls.dev REST API. Plans from $39.99/month — full transcripts, speaker segments, full-text search, and the recently-added /api/v1/transcripts/recent polling endpoint for ETL pipelines.

More tools for stock research

OptionsBell: an unusual options activity scanner that tracks options flow across all US stocks and emails you when large trades appear in Orkla ASA or any ticker on your watchlist.

StockMarketScan: a stock screener with alerts: 24 pre-built screens refreshed every 5 minutes, watchlists and email notifications. Both offer API and MCP access and fair monthly pricing.